Authors:
GADE R
MUHLEMAN D
BLAKE H
MACMURRAY J
JOHNSON P
VERDE R
SAUCIER G
COMINGS DE
Citation: R. Gade et al., CORRELATION OF LENGTH OF VNTR ALLELES AT THE X-LINKED MAOA GENE AND PHENOTYPIC EFFECT IN TOURETTE-SYNDROME AND DRUG-ABUSE, Molecular psychiatry, 3(1), 1998, pp. 50-60
Authors:
COMINGS D
GADEANDAVOLU R
GONZALEZ N
WU S
MUHLEMAN D
BLAKE H
DIETZ G
SAUCIER G
MACMURRAY J
Citation: D. Comings et al., MULTIPLE ADDITIVE ASSOCIATIONS - A TECHNIQUE FOR THE IDENTIFICATION OF GENES IN POLYGENIC DISORDERS, American journal of medical genetics, 81(6), 1998, pp. 489-489
Authors:
MACMURRAY J
WU S
MUHLEMAN D
GADEANDAVOLU R
BLAKE H
PETERS W
JOHNSON JP
SAUCIER G
COMINGS DE
Citation: J. Macmurray et al., ASSOCIATIONS BETWEEN THE GAMMA-INTERFERON GENE (IFNG3), ASTHENIA, ANDOBESITY, American journal of medical genetics, 81(6), 1998, pp. 524-524
Authors:
JOHNSON JP
DIETZ G
GADEANDAVOLU R
BLAKE H
MUHLEMAN D
SAUCIER G
MACMURRAY J
COMINGS DE
Citation: Jp. Johnson et al., ASSOCIATION OF ENDOPEPTIDASE (CD10NE) DINUCLEOTIDE REPEAT POLYMORPHISM WITH ANXIETY, DEPRESSION, AND P300 AMPLITUDE, American journal of medical genetics, 81(6), 1998, pp. 524-524
Citation: D. Comings et al., ANDROGEN RECEPTOR GENE, CONDUCT, AND OPPOSITIONAL DEFIANT DISORDER, American journal of medical genetics, 81(6), 1998, pp. 549-550
Authors:
BLAKE H
MACMURRAY J
GADEANDAVOLU R
WU S
MUHLEMAN D
DIETZ G
JOHNSON JP
SAUCIER G
COMINGS DE
Citation: H. Blake et al., GENDER DIFFERENCES IN APOE-ASSOCIATED BRAIN WEIGHTS OF ALZHEIMERS-DISEASE CASES, American journal of medical genetics, 81(6), 1998, pp. 554-554
Authors:
GADEANDAVOLU R
MACMURRAY JP
BLAKE H
MUHLEMAN D
TOURTELLOTTE W
COMINGS DE
Citation: R. Gadeandavolu et al., ASSOCIATION BETWEEN THE GAMMA-AMINOBUTYRIC-ACID A(3) RECEPTOR GENE AND MULTIPLE-SCLEROSIS, Archives of neurology, 55(4), 1998, pp. 513-516
Authors:
JOHNSON JP
MUHLEMAN D
MACMURRAY J
GADE R
VERDE R
ASK M
KELLEY J
COMINGS DE
Citation: Jp. Johnson et al., ASSOCIATION BETWEEN THE CANNABINOID RECEPTOR GENE (CNR1) AND THE P300EVENT-RELATED POTENTIAL, Molecular psychiatry, 2(2), 1997, pp. 169-171
Authors:
COMINGS DE
GADE R
WU S
CHIU C
DIETZ G
MUHLEMAN D
SAUCIER G
FERRY L
ROSENTHAL RJ
LESIEUR HR
RUGLE LJ
MACMURRAY P
Citation: De. Comings et al., STUDIES OF THE POTENTIAL ROLE OF THE DOPAMINE D-1 RECEPTOR GENE IN ADDICTIVE BEHAVIORS, Molecular psychiatry, 2(1), 1997, pp. 44-56
Authors:
BLAKE H
GADE R
MACMURRAY J
MUHLEMAN D
COMINGS D
Citation: H. Blake et al., GENDER DIFFERENCES IN PRESENILIN-1 GENE ASSOCIATIONS WITH MULTIPLE-SCLEROSIS, American journal of medical genetics, 74(6), 1997, pp. 643-643
Authors:
MACMURRAY J
GADE R
BLAKE H
MUHLEMAN D
COMINGS D
Citation: J. Macmurray et al., CONFOUNDING PRESENILIN-1 GENE EFFECT BETWEEN ALZHEIMERS-DISEASE AND SMOKING, American journal of medical genetics, 74(6), 1997, pp. 655-655
Authors:
COMINGS DE
GADE R
MACMURRAY JP
MUHLEMAN D
PETERS WR
Citation: De. Comings et al., GENETIC-VARIANTS OF THE HUMAN OBESITY (OB) GENE - ASSOCIATION WITH BODY-MASS INDEX IN YOUNG-WOMEN, PSYCHIATRIC-SYMPTOMS, AND INTERACTION WITH THE DOPAMINE D-2 RECEPTOR (DRD2) GENE, Molecular psychiatry, 1(4), 1996, pp. 325-335
Authors:
COMINGS DE
GADE R
MUHLEMAN D
CHIU C
WU SJ
TO M
SPENCE M
DIETZ G
WINNDEEN E
ROSENTHAL RJ
LESIEUR HR
RUGLE L
SVERD J
FERRY L
JOHNSON JP
MACMURRAY JP
Citation: De. Comings et al., EXON AND INTRON VARIANTS IN THE HUMAN TRYPTOPHAN 2,3-DIOXYGENASE GENE- POTENTIAL ASSOCIATION WITH TOURETTE SYNDROME, SUBSTANCE-ABUSE AND OTHER DISORDERS, Pharmacogenetics, 6(4), 1996, pp. 307-318
Authors:
COMINGS DE
WU S
CHIU C
RING RH
GADE R
AHN C
MACMURRAY JP
DIETZ G
MUHLEMAN D
Citation: De. Comings et al., POLYGENIC INHERITANCE OF TOURETTE SYNDROME, STUTTERING, ATTENTION-DEFICIT HYPERACTIVITY, CONDUCT, AND OPPOSITIONAL DEFIANT DISORDER - THE ADDITIVE AND SUBTRACTIVE EFFECT OF THE 3 DOPAMINERGIC GENES - DRD2, D-BETA-H, AND DAT1, American journal of medical genetics, 67(3), 1996, pp. 264-288
Citation: De. Comings et al., DOPAMINE D-2 RECEPTOR (DRD2) GENE AND SUSCEPTIBILITY TO POSTTRAUMATIC-STRESS-DISORDER - A STUDY AND REPLICATION, Biological psychiatry, 40(5), 1996, pp. 368-372
Authors:
COMINGS DE
MUHLEMAN D
DIETZ G
SHERMAN M
FOREST GL
Citation: De. Comings et al., SEQUENCE OF HUMAN TRYPTOPHAN 2,3-DIOXYGENASE (TDO2) - PRESENCE OF A GLUCOCORTICOID RESPONSE-LIKE ELEMENT COMPOSED OF A GTT REPEAT AND AN INTRONIC CCCCT REPEAT, Genomics, 29(2), 1995, pp. 390-396
Citation: De. Comings et al., NO ASSOCIATION OF A TYROSINE-HYDROXYLASE GENE TETRANUCLEOTIDE REPEAT POLYMORPHISM IN AUTISM, TOURETTE SYNDROME, OR ADHD, Biological psychiatry, 37(7), 1995, pp. 484-486
Authors:
COMINGS DE
MACMURRAY J
JOHNSON P
DIETZ G
MUHLEMAN D
Citation: De. Comings et al., DOPAMINE D2 RECEPTOR GENE (DRD2) HAPLOTYPES AND THE DEFENSE STYLE QUESTIONNAIRE IN SUBSTANCE-ABUSE, TOURETTE SYNDROME, AND CONTROLS, Biological psychiatry, 37(11), 1995, pp. 798-805
Authors:
COMINGS DE
WU S
CHIU H
RING RH
AHN C
MUHLEMAN D
DIETZ G
GADE R
Citation: De. Comings et al., POLYGENIC INHERITANCE AT A MOLECULAR-LEVEL - THE ADDITIVE EFFECT OF 3DOPAMINERGIC GENES IN TOURETTE SYNDROME, ADHD AND CONDUCT DISORDER, American journal of human genetics, 57(4), 1995, pp. 1372-1372
Authors:
COMINGS DE
MUHLEMAN D
AHN C
GYSIN R
FLANAGAN SD
Citation: De. Comings et al., THE DOPAMINE-D(2) RECEPTOR GENE - A GENETIC RISK FACTOR IN SUBSTANCE-ABUSE, Drug and alcohol dependence, 34(3), 1994, pp. 175-180
Authors:
COMINGS DE
FLANAGAN SD
DIETZ G
MUHLEMAN D
KNELL E
GYSIN R
Citation: De. Comings et al., THE DOPAMINE-D(2) RECEPTOR (DRD2) AS A MAJOR GENE IN OBESITY AND HEIGHT, Biochemical medicine and metabolic biology, 50(2), 1993, pp. 176-185